Piperacillin/Tazobactam 3.375 g Dosing Frequency
For most adult patients with serious infections (excluding nosocomial pneumonia), piperacillin/tazobactam 3.375 g should be administered every 6 hours by intravenous infusion over 30 minutes. 1
Standard Dosing by Indication
Non-Nosocomial Pneumonia Infections
- Standard dose: 3.375 g every 6 hours (total daily dose: 13.5 g)
- Infusion time: 30 minutes
- Duration: 7-10 days typically 1
This applies to:
- Intra-abdominal infections 2
- Skin and soft tissue infections 1
- Pelvic infections 1
- Community-acquired pneumonia 1
Nosocomial Pneumonia
- Higher dose required: 4.5 g every 6 hours (not 3.375 g)
- Add aminoglycoside for empiric coverage 1
Dosing Adjustments for Renal Impairment
Critical consideration: The 3.375 g every 6-hour regimen is ONLY appropriate for patients with creatinine clearance >40 mL/min 1
For renal impairment:
- CrCl 20-40 mL/min: Reduce to 2.25 g every 6 hours
- CrCl <20 mL/min: Reduce to 2.25 g every 8 hours
- Hemodialysis: 2.25 g every 12 hours plus 0.75 g after each dialysis session
Optimized Dosing Strategies
Extended/Continuous Infusion Considerations
While the FDA-approved standard is 3.375 g every 6 hours over 30 minutes, emerging evidence supports extended infusion strategies for critically ill patients and those with resistant organisms:
- Extended infusion: 3.375 g infused over 4 hours every 8 hours achieves superior pharmacodynamic targets 3, 4
- For Pseudomonas aeruginosa: Extended infusion (3-4 hours) significantly improves outcomes in critically ill patients, with 14-day mortality reduced from 31.6% to 12.2% (p=0.04) 3
- Continuous infusion: Recommended by recent guidelines for septic shock patients and those with APACHE II ≥20 5, 6
When to Consider Higher Frequency or Extended Infusion
Every 4-hour dosing (3.375 g every 4 hours) may be warranted for:
- Pseudomonas aeruginosa infections with MIC approaching susceptibility breakpoint 2
- Critically ill patients with augmented renal clearance 7
- Patients not responding to standard dosing
Important caveat: 37% of ICU patients receiving standard dosing fail to achieve therapeutic trough concentrations, particularly those with normal-to-augmented renal clearance 7. These patients may require more aggressive regimens.
Pediatric Dosing (≥2 months, <40 kg)
- Ages 2-9 months: 90 mg/kg every 8 hours for appendicitis/peritonitis; every 6 hours for nosocomial pneumonia
- >9 months: 112.5 mg/kg every 8 hours for appendicitis/peritonitis; every 6 hours for nosocomial pneumonia 1
Key Clinical Pitfalls
- Do not use 3.375 g for nosocomial pneumonia - requires 4.5 g dose 1
- Adjust for renal function - failure to reduce dose in renal impairment risks toxicity 1
- Consider therapeutic drug monitoring in critically ill patients, as standard dosing achieves subtherapeutic levels in over one-third of ICU patients 7
- Augmented renal clearance in younger critically ill patients often requires higher doses or extended infusion to achieve targets 7, 8